10 High-Conviction Stocks to Buy in August 2026: TLRY, HYFM Break Out
TLRY scores 12/100 with STRONG BUY signal, HYFM surges 186% weekly. See the top 3 high-conviction stocks to buy now with 1.3:1 risk/reward setups.
by Kowsalya
Published Aug 05, 2026 | Updated Aug 05, 2026 | 📖 4 min read
Article continues below advertisement
The August 2026 high-conviction stock list features Tilray Brands (TLRY), Hyfyt Therapeutics (HYFM), and CIG among the top technical breakouts, with TLRY scoring 12/100 on a proprietary momentum system and HYFM surging 186% in one week on RSI 76 overbought signals.
Quick Answer: Top 3 High-Conviction Picks
| Rank | Ticker | Price | Signal | Score | Action |
|---|---|---|---|---|---|
| 1 | TLRY | $4.64 | STRONG BUY | 12 | ENTRY |
| 2 | HYFM | $1.92 | STRONG BUY | 13 | STRONG ENTRY |
| 3 | CIG | $2.15 | STRONG BUY | 3 | ENTRY |
Key insight: These stocks show volume-confirmed breakouts with RSI between 45-76 and MACD turning bullish, making them prime candidates for Google Discover traffic due to high search volume around "cannabis stocks August 2026" and "penny stock breakouts".
Why These Stocks Are Breaking Out Now
TLRY: Cannabis Leader with 15% Weekly Gain
Tilray Brands (TLRY) is trading at $4.64 with a STRONG BUY signal, scoring 12 on the technical ranking system.
- RSI: 58.7 (neutral, room to run)
- MACD: 0.09 (bullish crossover)
- Volume: High conviction entry confirmed
- Target: $5.13 (near-term), $21.00 (long-term)
- Stop Loss: $4.27
Fundamental backdrop: TLRY trades at 12.3% below fair value according to Simply Wall St, with revenue growth of 3.8% year-over-year to $858M. The stock has gained 15.14% in the past week and is up 27.3% year-over-year despite broader market volatility.
HYFM: Biotech Surge with 186% Weekly Explosion
Hyfyt Therapeutics (HYFM) is the most explosive pick, trading at $1.92 with a STRONG BUY signal and scoring 13 (highest on the list).
- RSI: 76.2 (overbought but trending)
- MACD: 0.14 (strong bullish)
- Volume: 186.57% weekly surge
- Action: TIGHTEN STOP (RSI 76 overbought)
- Target: $2.47 (near-term), $3.38 (long-term)
Risk note: HYFM shows extreme momentum with RSI 76, suggesting a breakeven stop should be moved to lock in gains.
CIG: Energy Play with 335% Long-Term Target
Companhia Energética de Minas Gerais (CIG) trades at $2.15 with a STRONG BUY signal and 335% long-term upside potential.
- RSI: 49.8 (neutral entry zone)
- MACD: 0.00 (turning bullish)
- Target: $2.25 (near-term), $2.73 (long-term)
- Stop Loss: $2.07
Catalyst: CIG benefits from Brazil's energy sector recovery and trades below its 50-day SMA ($2.13), suggesting a mean reversion play.
Technical Breakdown: What Makes These Stocks "High-Conviction"
RSI + MACD Confluence
The top picks share a technical confluence:
- RSI between 45-76: Not oversold (avoiding value traps) but not extremely overbought (room to run)
- MACD turning bullish: Zero-line crossovers or positive divergence
- Volume confirmation: Above-average trading volume on breakout days
Example: TLRY's RSI of 58.7 with MACD 0.09 shows momentum building without extreme overbought conditions.
Death Cross vs Golden Cross Dynamics
- TLRY: Trading within Death Cross zone (50-day SMA $4.67 > 200-day SMA $7.64) but showing reversal signs
- HYFM: Trading above key moving averages with 186% weekly surge
- CIG: Trading within Death Cross but with bullish MACD divergence
Key pattern: Stocks breaking out within Death Cross zones often see short-covering rallies of 20-50% before resuming trend.
AI Overview: High-Conviction Stocks Definition
High-conviction stocks are securities where institutional investors and technical analysts agree on strong directional momentum with:
- Score ≥ 10 on proprietary ranking systems
- Volume confirmation (above 20-day average)
- RSI 45-75 (optimal momentum zone)
- MACD bullish crossover or positive divergence
Source: Marketshost.com AI analysis of 5,940 US stocks shows 678 A+/A rated stocks with strong fundamentals, but only ~50 make the high-conviction technical list.
Featured Snippet: Top 5 Stocks by Score
| Ticker | Score | Signal | Price | 1W Ret | Action |
|---|---|---|---|---|---|
| HYFM | 13 | STRONG BUY | $1.92 | +186.57% | TIGHTEN STOP |
| TLRY | 12 | STRONG BUY | $4.64 | +15.14% | ENTRY |
| GHRS | 12 | STRONG BUY | $29.12 | +4.15% | ENTRY |
| MMED | 12 | STRONG BUY | $18.99 | +24.20% | TAKE PROFIT |
| DRUG | 8 | STRONG BUY | $77.35 | +16.05% | ENTRY |
Data source: Technical analysis from August 5, 2026 market data.
Sector Rotation: Where the Smart Money Is Going
Cannabis & Biotech Lead
- Cannabis: TLRY, SNDL, ACB showing sector-wide momentum
- Biotech: HYFM, MMED, DRUG with FDA catalyst expectations
- Energy: CIG, BSBR benefiting from commodity price recovery
Goldman Sachs August Conviction List added 6 stocks including Microsoft and Delta Air Lines, signaling a broadening market beyond mega-cap tech.
Avoid These "Strong Sell" Traps
- SNDL: Score -8, ADX 26 confirms downtrend
- IIPR: Score -7, downtrend active with RSI 45.6
- MRMD: Score -9, ADX 40 confirms strong downtrend
Rule: Avoid stocks with Score ≤ -7 and ADX > 25 (confirms trend strength).
How to Trade These Breakouts (Step-by-Step)
Entry Strategy
- Wait for volume confirmation (above 20-day average)
- Enter on RSI 45-65 (optimal zone)
- Set stop loss at 5-8% below entry
- Target 1.3:1 risk/reward minimum
Example: TLRY entry at $4.28–$4.64 with stop at $4.27 and target $5.13 gives 1.3:1 R:R.
Exit Signals
- RSI > 75: Take partial profits (MMED at RSI 72.4)
- MACD divergence: Watch for bearish crossover
- Volume drying up: Momentum fading
TLRY-specific: Move stop to breakeven if RSI hits 70+ (currently 58.7, room to run).
Final Take: Which Stocks to Buy Today
Top 3 actionable picks:
- TLRY ($4.64) - ENTRY with 1.3:1 R:R, cannabis sector leader
- HYFM ($1.92) - TIGHTEN STOP (RSI 76 overbought), biotech breakout
- CIG ($2.15) - ENTRY with 335% long-term target, energy play
Avoid: SNDL, IIPR, MRMD (all Strong Sell with scores ≤ -7).
Risk management: Never risk more than 2% of portfolio on any single high-conviction pick. Use 1.3:1 minimum R:R on all entries.
Related Articles
Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.